Pages that link to "Q81157673"
Jump to navigation
Jump to search
The following pages link to Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine (Q81157673):
Displaying 50 items.
- DNA immunization as a technology platform for monoclonal antibody induction (Q26751432) (← links)
- DNA vaccines for HIV: challenges and opportunities. (Q30357322) (← links)
- Molecular mechanisms for enhanced DNA vaccine immunogenicity. (Q30366743) (← links)
- Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses. (Q30368929) (← links)
- Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1). (Q30379200) (← links)
- Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice (Q30394323) (← links)
- Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines. (Q33698142) (← links)
- Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopes (Q33837215) (← links)
- Bioinformatics in new generation flavivirus vaccines (Q33839001) (← links)
- The influence of delivery vectors on HIV vaccine efficacy (Q34077543) (← links)
- Heterodimeric barnase-barstar vaccine molecules: influence of one versus two targeting units specific for antigen presenting cells (Q34428944) (← links)
- Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response. (Q34540352) (← links)
- DNA vaccines: ready for prime time? (Q34824179) (← links)
- Mechanisms of immunization against cancer using chimeric antigens (Q35442846) (← links)
- Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag. (Q35750430) (← links)
- Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine. (Q35826610) (← links)
- Vector Design for Improved DNA Vaccine Efficacy, Safety and Production (Q35826665) (← links)
- HIV DNA Vaccine: Stepwise Improvements Make a Difference (Q35826742) (← links)
- Overcoming the Refractory Expression of Secreted Recombinant Proteins in Mammalian Cells through Modification of the Signal Peptide and Adjacent Amino Acids (Q36022211) (← links)
- Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially (Q36249053) (← links)
- The future of human DNA vaccines (Q36438236) (← links)
- Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens (Q36477717) (← links)
- Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business". (Q36498186) (← links)
- Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice (Q36528895) (← links)
- Vaccinia and influenza A viruses select rather than adjust tRNAs to optimize translation. (Q36580893) (← links)
- DNA prime-protein boost using subtype consensus Env was effective in eliciting neutralizing antibody responses against subtype BC HIV-1 viruses circulating in China. (Q36694841) (← links)
- Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates (Q36694846) (← links)
- Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens (Q36736400) (← links)
- Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration (Q36748019) (← links)
- Posttranscriptional regulatory elements enhance antigen expression and DNA vaccine efficacy (Q37284470) (← links)
- The effects of HIV Tat DNA on regulating the immune response of HIV DNA vaccine in mice (Q37364423) (← links)
- Comparative study of synonymous codon usage variations between the nucleocapsid and spike genes of coronavirus, and C-type lectin domain genes of human and mouse (Q37411209) (← links)
- The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods (Q37464882) (← links)
- Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years. (Q37530450) (← links)
- Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1) (Q37530471) (← links)
- DNA immunization (Q37576264) (← links)
- Immunologic Basis of Vaccine Vectors (Q37804532) (← links)
- DNA vaccines: an historical perspective and view to the future (Q37825523) (← links)
- DNA Immunization for HIV Vaccine Development (Q38581981) (← links)
- Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines (Q39320921) (← links)
- Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines (Q40263910) (← links)
- Optimized FaeG expression and a thermolabile enterotoxin DNA adjuvant enhance priming of an intestinal immune response by an FaeG DNA vaccine in pigs (Q41879113) (← links)
- Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines (Q41933070) (← links)
- Optimization of the immunogenicity of a DNA vaccine encoding a bacterial outer membrane lipoprotein (Q42216302) (← links)
- Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo. (Q43794420) (← links)
- Profiles of B and T cell immune responses elicited by different forms of the hepatitis B virus surface antigen (Q44014135) (← links)
- Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera (Q45129797) (← links)
- Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines (Q45411804) (← links)
- The dynamics of immunoglobulin V-gene usage and clonotype expansion in mice after prime and boost immunizations as analyzed by NGS. (Q47113130) (← links)
- Enhancement of plasmid DNA immunogenicity with linear polyethylenimine (Q50943143) (← links)